Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
British Journal of Cancer
|
July 5, 2001
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)
S Tejpar, C Li, C Yu, et al.
Acta Gastro-Enterologica Belgica
|
November 23, 2011
The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP)
Kathleen Claes, Karin Dahan, S Tejpar, et al.
The Journal of Pathology
|
May 1, 2001
Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours
C E Clavel, F Nollet, G Berx, et al.
Acta Gastro-Enterologica Belgica
|
March 19, 2022
Prevalence of microsatellite instable and Epstein-Barr Virus-driven gastroesophageal cancer in a large Belgian cohort
S De Meulder, X Sagaert, H Brems, et al.
Seminars in Cancer Biology
|
January 9, 2018
A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design
M Morfouace, S M Hewitt, R Salgado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Clinical and molecular characteristics and treatment outcomes of advanced right-colon, left-colon and rectal cancers: data from 1180 patients in a phase III trial of panitumumab with an extended biomarker panel
J F Seligmann, F Elliott, S Richman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 5, 2015
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer
C Bokemeyer, C-H Köhne, F Ciardiello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2022
Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe
A Lamarca, M Morfouace, S Tejpar, et al.
British Journal of Cancer
|
May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer
T Macarulla, A Cervantes, J Tabernero, et al.
British Journal of Cancer
|
April 1, 2004
Invasion and MMP expression profile in desmoid tumours
H Denys, O De Wever, B Nusgens, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
British Journal of Cancer
|
July 5, 2001
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)
S Tejpar, C Li, C Yu, et al.
Acta Gastro-Enterologica Belgica
|
November 23, 2011
The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP)
Kathleen Claes, Karin Dahan, S Tejpar, et al.
The Journal of Pathology
|
May 1, 2001
Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours
C E Clavel, F Nollet, G Berx, et al.
Acta Gastro-Enterologica Belgica
|
March 19, 2022
Prevalence of microsatellite instable and Epstein-Barr Virus-driven gastroesophageal cancer in a large Belgian cohort
S De Meulder, X Sagaert, H Brems, et al.
Seminars in Cancer Biology
|
January 9, 2018
A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design
M Morfouace, S M Hewitt, R Salgado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Clinical and molecular characteristics and treatment outcomes of advanced right-colon, left-colon and rectal cancers: data from 1180 patients in a phase III trial of panitumumab with an extended biomarker panel
J F Seligmann, F Elliott, S Richman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 5, 2015
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer
C Bokemeyer, C-H Köhne, F Ciardiello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2022
Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe
A Lamarca, M Morfouace, S Tejpar, et al.
British Journal of Cancer
|
May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer
T Macarulla, A Cervantes, J Tabernero, et al.
British Journal of Cancer
|
April 1, 2004
Invasion and MMP expression profile in desmoid tumours
H Denys, O De Wever, B Nusgens, et al.
Page
of 5